Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Audited Financial Results For The Period Ended On March 31, 2018 - Correction Of Typo

 This is with reference to our submission of Audited Financial Results on 28-05-2018. In this regard we wish to inform you that there is a typo in the financial results for the period ended on 31.03.2018. In column no. 4 (year ended Standalone results for 31-Mar-18) and in column no. 5 (year ended Standalone results for 31-Mar-17) the word 'Unaudited' has been inadvertently written instead of 'Audited'. We would like to inform that there is no change...
30-05-2018
Bigul

Corporate Action-Board approves Dividend

 The Board of Directors in their meeting held on May 28, 2018 have recommended the 5% Final Dividend i.e. Re. 0.05 per equity share to the members of the company, out of profits of the company for the financial year 2017-2018, subject to the approval of the members in their Annual General Meeting.
28-05-2018
Bigul

Board recommends Final Dividend

 Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2018, inter alia, has recommended the Final Dividend of Re. 0.05/- per equity share (5% on the face value of Re. 1/- per equity share) for the financial year 2017-18, subject to the approval of Members at their Annual General Meeting.
28-05-2018
Bigul

Audited Financial Results For The Year Ended March 31, 2018

 Please find enclosed herewith a copy of the Audited Financial Results (Standalone and Consolidated) for the period ended on March 31, 2018, as approved by the Board of Directors in their meeting held on even date i.e. May 28, 2018. A copy of the Auditor''s Report is also enclosed herewith for your record please. The declaration that audit reports do not contain any modified opinion is also attached.
28-05-2018
Bigul

Annual report for Nectar Lifesciences Ltd. for FY-2018
28-05-2018
Bigul

Board to consider Final Dividend

 Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 28, 2018, inter alia, to consider and approve:1. The Audited Financial Results for the Financial Year 2017-18, Financial Statements of the Company for the Financial Year 2017-18 and matters related thereto.2. Recommendation of final dividend to the Members of the Company for Financial Year 2017-18....
21-05-2018
Bigul

Board Meeting On May 28, 2018

 Notice of Board Meeting on May 28, 2018 for Audited Financial Results and Dividend and Notice of Trading Window as attached.
21-05-2018
Bigul

Compliance Certificate For The Half Year Ended On March 31, 2018.

 Pursuant to regulation 7(3) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the certificate for the half year ended on March 31, 2018.
11-04-2018
Bigul

Shareholding for the Period Ended March 31, 2018

 Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
06-04-2018
Bigul

Compliance Under Regulation 40(10) Of The SEBI (LODR) Regulations, 2015.

 Pursuant to Regulation 40(10)of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of said Regulations, for the half year ended March 31, 2018.
05-04-2018
Next Page
Close

Let's Open Free Demat Account